Are hematopoietic colony-stimulating factors useful in association with chemotherapy in the treatment of HIV-related non-Hodgkin's lymphomas?

被引：0
|
作者：
Errante, D [1 ]
Vaccher, E [1 ]
Tirelli, U [1 ]
机构：
[1] CTR RIFERIMENTO ONCOL,DIV MED ONCOL & AIDS,I-33081 AVIANO,ITALY
来源：
ANNALS OF ONCOLOGY | 1996年 / 7卷 / 03期
关键词：
colony stimulating factors; HIV; non-Hodgkin's lymphoma; treatment;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：233 / 237
页数：5
相关论文
共 50 条
  • [31] Effect of recombinant human granulocyte-macrophage colony-stimulating factor on HIV-related leukopenia: a randomized, controlled clinical study
    Barbaro, G
    DiLorenzo, G
    Grisorio, B
    Soldini, M
    Barbarini, G
    AIDS, 1997, 11 (12) : 1453 - 1461
  • [32] Is chemotherapy scoring useful to predict progenitor cell mobilisation in patients with non-Hodgkin's lymphoma?
    Jantunen, E
    Kuittinen, T
    Nousiainen, T
    BONE MARROW TRANSPLANTATION, 2003, 32 (06) : 569 - 573
  • [33] Is chemotherapy scoring useful to predict progenitor cell mobilisation in patients with non-Hodgkin's lymphoma?
    E Jantunen
    T Kuittinen
    T Nousiainen
    Bone Marrow Transplantation, 2003, 32 : 569 - 573
  • [34] The follicular non-Hodgkin's lymphomas .2. Prognostic factors: What do they mean?
    Denham, JW
    Denham, E
    Dear, KB
    Hudson, GV
    EUROPEAN JOURNAL OF CANCER, 1996, 32A (03) : 480 - 490
  • [35] HIV-1 Tat induces DNMT over-expression through microRNA dysregulation in HIV-related non Hodgkin lymphomas
    Anna Luzzi
    Federica Morettini
    Sara Gazaneo
    Lucia Mundo
    Anna Onnis
    Susanna Mannucci
    Emily A Rogena
    Cristiana Bellan
    Lorenzo Leoncini
    Giulia De Falco
    Infectious Agents and Cancer, 9
  • [36] HIV-1 Tat induces DNMT over-expression through microRNA dysregulation in HIV-related non Hodgkin lymphomas
    Luzzi, Anna
    Morettini, Federica
    Gazaneo, Sara
    Mundo, Lucia
    Onnis, Anna
    Mannucci, Susanna
    Rogena, Emily A.
    Bellan, Cristiana
    Leoncini, Lorenzo
    De Falco, Giulia
    INFECTIOUS AGENTS AND CANCER, 2014, 9
  • [37] Differences between patients with non-Hodgkin's lymphomas in a cohort of HIV/AIDS patients in Puerto Rico
    Mayor, AM
    Gomez, MA
    Rios, E
    Hunter, RF
    CELLULAR AND MOLECULAR BIOLOGY, 2003, 49 (07) : 1145 - 1149
  • [38] Ofatumumab in the treatment of low-grade non-Hodgkin's lymphomas and chronic lymphocytic leukemia
    Bello, Celeste
    Veliz, Marays
    Pinilla-Ibarz, Javier
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2011, 7 (03) : 295 - 300
  • [39] Axicabtagene ciloleucel for the treatment of relapsed/refractory B-cell non-Hodgkin's lymphomas
    Sharma, P.
    King, G. T.
    Shinde, S. S.
    Purev, E.
    Jimeno, A.
    DRUGS OF TODAY, 2018, 54 (03) : 187 - 198
  • [40] Expression of P53 predicts treatment failure in aggressive non-Hodgkin's lymphomas
    Navaratnam, S
    Williams, GJ
    Rubinger, M
    Pettigrew, NM
    Mowat, MRA
    Begleiter, A
    Johnston, JB
    LEUKEMIA & LYMPHOMA, 1998, 29 (1-2) : 139 - 144
12345